|
1
|
Ramos-Casals M, Brito-Zerón P and Font J:
The overlap of Sjögren’s syndrome with other systemic autoimmune
diseases. Semin Arthritis Rheum. 36:246–255. 2007.
|
|
2
|
Ramos-Casals M, Tzioufas AG and Font J:
Primary Sjögren’s syndrome: new clinical and therapeutic concepts.
Ann Rheum Dis. 64:347–354. 2005.
|
|
3
|
Fox RI, Stern M and Michelson P: Update in
Sjögren syndrome. Curr Opin Rheumatol. 12:391–398. 2000.
|
|
4
|
Tang W, Lu Y, Tian QY, et al: The growth
factor progranulin binds to TNF receptors and is therapeutic
against inflammatory arthritis in mice. Science. 332:478–484. 2011.
View Article : Google Scholar
|
|
5
|
Hochberg MC: Updating the American College
of Rheumatology revised criteria for the classification of systemic
lupus erythematosus. Arthritis Rheum. 40:17251997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hrabal R, Chen Z, James S, Bennett HP and
Ni F: The hairpin stack fold, a novel protein architecture for a
new family of protein growth factors. Nat Struct Biol. 3:747–752.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bateman A and Bennett HP: The granulin
gene family: from cancer to dementia. Bioessays. 31:1245–1254.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Feng JQ, Guo FJ, Jiang BC, et al: Granulin
epithelin precursor: a bone morphogenic protein 2-inducible growth
factor that activates Erk1/2 signaling and JunB transcription
factor in chondrogenesis. FASEB J. 24:1879–1892. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Daniel R, He Z, Carmichael KP, Halper J
and Bateman A: Cellular localization of gene expression for
progranulin. J Histochem Cytochem. 48:999–1009. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
He Z, Ong CH, Halper J and Bateman A:
Progranulin is a mediator of the wound response. Nat Med.
9:225–229. 2003. View
Article : Google Scholar
|
|
11
|
Kessenbrock K, Fröhlich L, Sixt M, et al:
Proteinase 3 and neutrophil elastase enhance inflammation in mice
by inactivating antiinflammatory progranulin. J Clin Invest.
118:2438–2447. 2008.PubMed/NCBI
|
|
12
|
Zhu J, Nathan C, Jin W, et al: Conversion
of proepithelin to epithelins: roles of SLPI and elastase in host
defense and wound repair. Cell. 111:867–878. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guo F, Lai Y, Tian Q, Lin EA, Kong L and
Liu C: Granulin-epithelin precursor binds directly to ADAMTS-7 and
ADAMTS-12 and inhibits their degradation of cartilage oligomeric
matrix protein. Arthritis Rheum. 62:2023–2036. 2010.PubMed/NCBI
|
|
14
|
Tishler M, Yaron I, Shirazi I, Yossipov Y
and Yaron M: Increased salivary interleukin-6 levels in patients
with primary Sjögren’s syndrome. Rheumatol Int. 18:125–127.
1999.PubMed/NCBI
|
|
15
|
Lotz M, Jirik F, Kabouridis P, Tsoukas C,
Hirano T, Kishimoto T and Carson DA: B cell stimulating factor
2/interleukin 6 is a costimulant for human thymocytes and T
lymphocytes. J Exp Med. 167:1253–1258. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Naka T, Nishimoto N and Kishimoto T: The
paradigm of IL-6: from basic science to medicine. Arthritis Res.
4(Suppl 3): S233–S242. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Suzuki H, Yasukawa K, Saito T, Narazaki M,
Hasegawa A, Taga T and Kishimoto T: Serum soluble interleukin-6
receptor in MRL/lpr mice is elevated with age and mediates the
interleukin-6 signal. Eur J Immunol. 23:1078–1082. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tang B, Matsuda T, Akira S, Nagata N,
Ikehara S, Hirano T and Kishimoto T: Age-associated increase in
interleukin 6 in MRL/lpr mice. Int Immunol. 3:273–278. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tackey E, Lipsky PE and Illei GG:
Rationale for interleukin-6 blockade in systemic lupus
erythematosus. Lupus. 13:339–343. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gröndal G, Gunnarsson I, Rönnelid J,
Rogberg S, Klareskog L and Lundberg I: Cytokine production, serum
levels and disease activity in systemic lupus erythematosus. Clin
Exp Rheumatol. 18:565–570. 2000.PubMed/NCBI
|
|
21
|
Eilertsen GØ, Nikolaisen C, Becker-Merok A
and Nossent JC: Interleukin-6 promotes arthritis and joint
deformation in patients with systemic lupus erythematosus. Lupus.
20:607–613. 2011.PubMed/NCBI
|
|
22
|
Mihara M, Nishimoto N and Ohsugi Y: The
therapy of autoimmune diseases by anti-interleukin-6 receptor
antibody. Expert Opin Biol Ther. 5:683–690. 2005. View Article : Google Scholar : PubMed/NCBI
|
